Credit Trends: Potential Downgrades Reach Another Record High Amid COVID-19 Stress | S&P Global Ratings
Teva Pharmaceuticals Ratings Cut at Fitch - TheStreet
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Fitch downgrades Teva debt - Globes
S&P downgrades Teva, pushing credit rating further into junk territory - Business - Haaretz.com
Teva May Have to Make Difficult Capital Allocation Decisions Under Pressure From Potential Generic Competition, Deleveraging Goals - Reorg
Credit Rating Process | A Complete Beginner's Guide
Teva Pharmaceutical (TEVA)
Teva: The Road To Perdition Has Turned Into A Path Towards Redemption (NYSE: TEVA) | Seeking Alpha
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Credit Rating Process | A Complete Beginner's Guide